110 related articles for article (PubMed ID: 12970918)
1. Studies on specific interaction of beta-2-glycoprotein I with HBsAg.
Gao PJ; Piao YF; Liu XD; Qu LK; Shi Y; Wang XC; Yang HY
World J Gastroenterol; 2003 Sep; 9(9):2114-6. PubMed ID: 12970918
[TBL] [Abstract][Full Text] [Related]
2. [Relation between Beta-2-glycoprotein I and hepatitis B virus surface antigen].
Gao P; Guo Y; Qu L; Shi T; Zhang H; Dong C; Yang H
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):31-3. PubMed ID: 11856498
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus surface antigen binds to apolipoprotein H.
Mehdi H; Kaplan MJ; Anlar FY; Yang X; Bayer R; Sutherland K; Peeples ME
J Virol; 1994 Apr; 68(4):2415-24. PubMed ID: 8139027
[TBL] [Abstract][Full Text] [Related]
4. An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently.
Mehdi H; Yang X; Peeples ME
Virology; 1996 Mar; 217(1):58-66. PubMed ID: 8599236
[TBL] [Abstract][Full Text] [Related]
5. High expression of beta2-glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection.
Liu YM; Zhang WY; Wang ZF; Yan CY; Gao PJ
J Med Virol; 2014 Aug; 86(8):1296-306. PubMed ID: 24760738
[TBL] [Abstract][Full Text] [Related]
6. Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H).
Mehdi H; Naqvi A; Kamboh MI
Biochim Biophys Acta; 2008 Mar; 1782(3):163-8. PubMed ID: 18230366
[TBL] [Abstract][Full Text] [Related]
7. Beta2-GPI: a novel factor in the development of hepatocellular carcinoma.
Jing X; Piao YF; Liu Y; Gao PJ
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1671-80. PubMed ID: 20204408
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus Dane particles bind to human plasma apolipoprotein H.
Stefas I; Rucheton M; D'Angeac AD; Morel-Baccard C; Seigneurin JM; Zarski JP; Martin M; Cerutti M; Bossy JP; Missé D; Graafland H; Veas F
Hepatology; 2001 Jan; 33(1):207-17. PubMed ID: 11124838
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
[TBL] [Abstract][Full Text] [Related]
10. LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles.
Vanlandschoot P; Van Houtte F; Roobrouck A; Farhoudi A; Stelter F; Peterson DL; Gomez-Gutierrez J; Gavilanes F; Leroux-Roels G
J Gen Virol; 2002 Sep; 83(Pt 9):2279-2289. PubMed ID: 12185283
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the association between beta 2-glycoprotein I and hepatotropism of hepatitis B virus].
Gao YH; Gao PJ; Wang D; Shi Y; Tang TY; Piao YF; Yang HY
Zhonghua Gan Zang Bing Za Zhi; 2006 Aug; 14(8):569-71. PubMed ID: 16938165
[TBL] [Abstract][Full Text] [Related]
12. The putative cell receptors for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV.
Neurath AR; Strick N
Virology; 1994 Oct; 204(1):475-7. PubMed ID: 8091682
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg.
Gao Y; Ma Y; Li M; Cheng T; Li SW; Zhang J; Xia NS
World J Gastroenterol; 2003 May; 9(5):996-1002. PubMed ID: 12717845
[TBL] [Abstract][Full Text] [Related]
14. A novel application of ion exchange chromatography in recombinant hepatitis B vaccine downstream processing: Improving recombinant HBsAg homogeneity by removing associated aggregates.
Kimia Z; Hosseini SN; Ashraf Talesh SS; Khatami M; Kavianpour A; Javidanbardan A
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1113():20-29. PubMed ID: 30877983
[TBL] [Abstract][Full Text] [Related]
15. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
[TBL] [Abstract][Full Text] [Related]
16. Improving the recovery of clarification process of recombinant hepatitis B surface antigen in large-scale by optimizing adsorption-desorption parameters on Aerosil-380.
Hosseini SN; Ghaisari P; Sharifnia S; Khatami M; Javidanbardan A
Prep Biochem Biotechnol; 2018; 48(6):490-497. PubMed ID: 29932813
[TBL] [Abstract][Full Text] [Related]
17. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1.
Cheng J; Imanishi H; Morisaki H; Liu W; Nakamura H; Morisaki T; Hada T
J Hepatol; 2005 Sep; 43(3):465-71. PubMed ID: 15963597
[TBL] [Abstract][Full Text] [Related]
18. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
[TBL] [Abstract][Full Text] [Related]
19. Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers.
Pfefferkorn M; Böhm S; Schott T; Deichsel D; Bremer CM; Schröder K; Gerlich WH; Glebe D; Berg T; van Bömmel F
Gut; 2018 Nov; 67(11):2045-2053. PubMed ID: 28951526
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.
Vanlandschoot P; Van Houtte F; Roobrouck A; Farhoudi A; Leroux-Roels G
J Gen Virol; 2002 Jun; 83(Pt 6):1281-1289. PubMed ID: 12029142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
